Capital Asset Advisory Services’s GSK GSK Stock Holding History

Capital Asset Advisory Services’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-146	Closed	-$7K	–	998
2020 Q4	$7K	Buy	+146	New	+$6.71K	﹤0.01%	1177
2017 Q4	–	Sell	-9,806	Closed	-$498K	–	112
2017 Q3	$498K	Buy	9,806 +208	+2%	+$10.6K	0.45%	57
2017 Q2	$519K	Sell	9,598 -175	-2%	-$9.33K	0.33%	67
2017 Q1	$515K	Sell	9,773 -897	-8%	-$45.5K	0.37%	53
2016 Q4	$514K	Sell	10,670 -185	-2%	-$9.14K	0.44%	45
2016 Q3	$585K	Sell	10,855 -4,450	-29%	-$244K	0.77%	24
2016 Q2	$829K	Sell	15,305 -209	-1%	-$11K	1.09%	17
2016 Q1	$786K	Hold	15,514	–	–	0.86%	30
2015 Q4	$783K	Buy	+15,514	New	+$791K	1.1%	22

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Capital Asset Advisory Services's GSK Position: Q1 2021 in Review

Capital Asset Advisory Services sold out of GSK (GSK) in Q1 2021, closing a stake of 146 shares — an estimated $7K sold.

Capital Asset Advisory Services first reported a position in GSK in Q4 2015 and held it in 9 quarters. The position peaked at $829K in Q2 2016. 774 funds tracked by Wall St. Rank hold GSK as of Q1 2021.

Capital Asset Advisory Services reported no remaining GSK position as of Q1 2021 after selling out during the quarter.
Capital Asset Advisory Services sold 146 GSK shares in Q1 2021, an estimated $7K.
Capital Asset Advisory Services first reported a position in GSK in Q4 2015 and held it in 9 quarters.
Capital Asset Advisory Services's GSK position peaked at $829K in Q2 2016.
774 funds tracked by Wall St. Rank held GSK as of Q1 2021.

Based on Capital Asset Advisory Services's 13F filing for Q1 2021, filed 13 May 2021.